NCT06670820View on ClinicalTrials.gov

ITBS in MCI and Mild AD

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Mild Cognitive Impairment (MCI)Mild Alzheimer Disease
Interventions
DEVICE

Active rTMS

iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total10 sessions

DEVICE

Sham rTMS

sham iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total 10 sessions

Trial Locations (1)

114

Tri-Service General Hospital, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER